Cellular and immune therapeutics manufacturer.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2024 | BAKER & HOSTETLER LLP |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Termination |
— |
| Firm | Filings | Expenses |
|---|---|---|
| BAKER & HOSTETLER LLP | 15 | — |
| Issue | Activities |
|---|---|
| Health Issues | 15 |